Build Your Comparison

Side-by-side financial analysis
ANL logo
ANL
CAN logo
CAN
MARA logo
MARA
ZLAB logo
ZLAB
JPM logo
JPM
Try popular comparisons:

Stock Comparison

ANL vs CAN vs MARA vs ZLAB vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ANL
Adlai Nortye Ltd.

Biotechnology

HealthcareNASDAQ • KY
Market Cap$322M
5Y Perf.-31.2%
CAN
Canaan Inc.

Computer Hardware

TechnologyNASDAQ • SG
Market Cap$203M
5Y Perf.-82.4%
MARA
Marathon Digital Holdings, Inc.

Financial - Capital Markets

Financial ServicesNASDAQ • US
Market Cap$5.37B
5Y Perf.+65.6%
ZLAB
Zai Lab Limited

Biotechnology

HealthcareNASDAQ • CN
Market Cap$1.89B
5Y Perf.-29.8%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+121.2%

ANL vs CAN vs MARA vs ZLAB vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ANL logoANL
CAN logoCAN
MARA logoMARA
ZLAB logoZLAB
JPM logoJPM
IndustryBiotechnologyComputer HardwareFinancial - Capital MarketsBiotechnologyBanks - Diversified
Market Cap$322M$203M$5.37B$1.89B$896.00B
Revenue (TTM)$6M$530M$868M$453M$280.33B
Net Income (TTM)$-54M$-210M$-2.04B$-178M$57.05B
Gross Margin100.0%7.8%0.3%57.9%60.0%
Operating Margin-10.0%-19.3%16.9%-53.5%25.9%
Forward P/E14.4x
Total Debt$27M$55M$3.65B$224M$942.38B
Cash & Equiv.$61M$81M$547M$680M$343.34B

ANL vs CAN vs MARA vs ZLAB vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ANL
CAN
MARA
ZLAB
JPM
StockSep 23Jun 26Return
Adlai Nortye Ltd. (ANL)10068.8-31.2%
Canaan Inc. (CAN)10017.6-82.4%
Marathon Digital Ho… (MARA)100165.6+65.6%
Zai Lab Limited (ZLAB)10070.2-29.8%
JPMorgan Chase & Co. (JPM)100221.2+121.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: ANL vs CAN vs MARA vs ZLAB vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM leads in 4 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Adlai Nortye Ltd. is the stronger pick specifically for recent price momentum and sentiment. CAN and MARA also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
ANL
Adlai Nortye Ltd.
The Momentum Pick

ANL is the #2 pick in this set and the best alternative if momentum is your priority.

  • +5.5% vs ZLAB's -60.3%
Best for: momentum
CAN
Canaan Inc.
The Growth Play

CAN ranks third and is worth considering specifically for growth exposure.

  • Rev growth 96.7%, EPS growth 51.1%, 3Y rev CAGR -6.7%
  • 96.7% revenue growth vs ANL's -100.0%
Best for: growth exposure
MARA
Marathon Digital Holdings, Inc.
The Banking Pick

MARA is the clearest fit if your priority is value.

  • Better valuation composite
Best for: value
ZLAB
Zai Lab Limited
The Defensive Pick

ZLAB is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.15, Low D/E 31.3%, current ratio 2.45x
  • Beta 1.15, current ratio 2.45x
Best for: sleep-well-at-night and defensive
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • 465.8% 10Y total return vs ANL's -31.2%
  • NIM 2.2% vs MARA's 0.1%
  • 20.4% margin vs ANL's -8.3%
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCAN logoCAN96.7% revenue growth vs ANL's -100.0%
ValueMARA logoMARABetter valuation composite
Quality / MarginsJPM logoJPM20.4% margin vs ANL's -8.3%
Stability / SafetyJPM logoJPMBeta 0.94 vs CAN's 4.24
DividendsJPM logoJPM1.9% yield; 15-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)ANL logoANL+5.5% vs ZLAB's -60.3%
Efficiency (ROA)JPM logoJPM1.3% ROA vs ANL's -50.2%, ROIC 4.5% vs -7.3%

ANL vs CAN vs MARA vs ZLAB vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Crypto Stocks Theme

These companies are key players in the Crypto Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
ANLAdlai Nortye Ltd.

Segment breakdown not available.

CANCanaan Inc.
FY 2025
Product
78.5%$414M
Mining
21.5%$113M
MARAMarathon Digital Holdings, Inc.
FY 2025
Hosting Services
100.0%$5M
ZLABZai Lab Limited
FY 2025
Zejula
56.5%$189M
Nuzyra
18.2%$61M
Optune
14.4%$48M
Qinlock
10.6%$36M
Product and Service, Other
0.2%$717,000
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

ANL vs CAN vs MARA vs ZLAB vs JPM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGZLAB

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 43194.6x ANL's $6M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to ANL's -8.3%. On growth, CAN holds the edge at +121.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricANL logoANLAdlai Nortye Ltd.CAN logoCANCanaan Inc.MARA logoMARAMarathon Digital …ZLAB logoZLABZai Lab LimitedJPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$6M$530M$868M$453M$280.3B
EBITDAEarnings before interest/tax-$64M-$140M$953M-$227M$81.4B
Net IncomeAfter-tax profit-$54M-$210M-$2.0B-$178M$57.0B
Free Cash FlowCash after capex-$67M$0-$385M-$129M$100.9B
Gross MarginGross profit ÷ Revenue+100.0%+7.8%+0.3%+57.9%+60.0%
Operating MarginEBIT ÷ Revenue-10.0%-19.3%+16.9%-53.5%+25.9%
Net MarginNet income ÷ Revenue-8.3%-39.7%-2.3%-39.3%+20.4%
FCF MarginFCF ÷ Revenue-10.3%-44.4%-28.5%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year+121.1%-6.5%
EPS Growth (YoY)Latest quarter vs prior year+78.7%+59.4%-113.5%-11.1%+16.0%
JPM leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

CAN leads this category, winning 2 of 3 comparable metrics.
MetricANL logoANLAdlai Nortye Ltd.CAN logoCANCanaan Inc.MARA logoMARAMarathon Digital …ZLAB logoZLABZai Lab LimitedJPM logoJPMJPMorgan Chase & …
Market CapShares × price$322M$203M$5.4B$1.9B$896.0B
Enterprise ValueMkt cap + debt − cash$289M$177M$8.5B$1.4B$1.50T
Trailing P/EPrice ÷ TTM EPS-2.11x-0.71x-3.82x-10.67x16.00x
Forward P/EPrice ÷ next-FY EPS est.14.40x
PEG RatioP/E ÷ EPS growth rate0.90x
EV / EBITDAEnterprise value multiple18.36x
Price / SalesMarket cap ÷ Revenue0.38x5.92x4.11x3.20x
Price / BookPrice ÷ Book value/share4.31x0.34x1.44x2.61x2.47x
Price / FCFMarket cap ÷ FCF8.88x
CAN leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

JPM leads this category, winning 4 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-101 for ANL. CAN carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CAN scores 6/9 vs ANL's 2/9, reflecting solid financial health.

MetricANL logoANLAdlai Nortye Ltd.CAN logoCANCanaan Inc.MARA logoMARAMarathon Digital …ZLAB logoZLABZai Lab LimitedJPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-101.3%-60.7%-51.7%-24.3%+15.9%
ROA (TTM)Return on assets-50.2%-34.6%-28.0%-15.5%+1.3%
ROICReturn on invested capital-7.3%-24.9%-9.0%-41.7%+4.5%
ROCEReturn on capital employed-103.8%-29.7%-12.1%-27.2%+8.9%
Piotroski ScoreFundamental quality 0–926335
Debt / EquityFinancial leverage1.07x0.13x1.05x0.31x2.60x
Net DebtTotal debt minus cash-$34M-$26M$3.1B-$455M$599.0B
Cash & Equiv.Liquid assets$61M$81M$547M$680M$343.3B
Total DebtShort + long-term debt$27M$55M$3.6B$224M$942.4B
Interest CoverageEBIT ÷ Interest expense-28.22x-104.53x12.66x-30.73x0.74x
JPM leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $680 for CAN. Over the past 12 months, ANL leads with a +545.0% total return vs ZLAB's -60.3%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CAN's -47.7% — a key indicator of consistent wealth creation.

MetricANL logoANLAdlai Nortye Ltd.CAN logoCANCanaan Inc.MARA logoMARAMarathon Digital …ZLAB logoZLABZai Lab LimitedJPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+647.8%-58.4%+42.1%-1.5%-0.5%
1-Year ReturnPast 12 months+545.0%-54.4%-11.0%-60.3%+21.8%
3-Year ReturnCumulative with dividends-31.2%-85.7%+50.9%-38.2%+138.2%
5-Year ReturnCumulative with dividends-31.2%-93.2%-53.0%-90.0%+118.2%
10-Year ReturnCumulative with dividends-31.2%-92.2%-66.0%-38.9%+465.8%
CAGR (3Y)Annualised 3-year return-11.7%-47.7%+14.7%-14.8%+33.6%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

JPM leads this category, winning 2 of 2 comparable metrics.

JPM is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than CAN's 4.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs CAN's 14.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricANL logoANLAdlai Nortye Ltd.CAN logoCANCanaan Inc.MARA logoMARAMarathon Digital …ZLAB logoZLABZai Lab LimitedJPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5001.39x4.24x3.32x1.15x0.94x
52-Week HighHighest price in past year$17.25$2.22$23.45$44.34$337.25
52-Week LowLowest price in past year$0.88$0.31$6.66$15.96$262.71
% of 52W HighCurrent price vs 52-week peak+59.8%+14.4%+60.0%+38.5%+95.1%
RSI (14)Momentum oscillator 0–10039.030.153.543.459.1
Avg Volume (50D)Average daily shares traded380K9.7M41.5M842K7.0M
JPM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

JPM leads this category, winning 1 of 1 comparable metric.

Analyst consensus: ANL as "Buy", CAN as "Buy", MARA as "Buy", ZLAB as "Buy", JPM as "Buy". Consensus price targets imply 337.2% upside for CAN (target: $1) vs -11.2% for MARA (target: $13). JPM is the only dividend payer here at 1.86% yield — a key consideration for income-focused portfolios.

MetricANL logoANLAdlai Nortye Ltd.CAN logoCANCanaan Inc.MARA logoMARAMarathon Digital …ZLAB logoZLABZai Lab LimitedJPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$26.00$1.40$12.50$35.00$339.75
# AnalystsCovering analysts16201161
Dividend YieldAnnual dividend ÷ price+1.9%
Dividend StreakConsecutive years of raises015
Dividend / ShareAnnual DPS$5.95
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.9%0.0%+3.9%
JPM leads this category, winning 1 of 1 comparable metric.
Key Takeaway

JPM leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CAN leads in 1 (Valuation Metrics).

Best OverallJPMorgan Chase & Co. (JPM)Leads 5 of 6 categories
Loading custom metrics...

ANL vs CAN vs MARA vs ZLAB vs JPM: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is ANL or CAN or MARA or ZLAB or JPM a better buy right now?

For growth investors, Canaan Inc.

(CAN) is the stronger pick with 96. 7% revenue growth year-over-year, versus -100. 0% for Adlai Nortye Ltd. (ANL). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Adlai Nortye Ltd. (ANL) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ANL or CAN or MARA or ZLAB or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -93. 2% for Canaan Inc. (CAN). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CAN's -92. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ANL or CAN or MARA or ZLAB or JPM?

By beta (market sensitivity over 5 years), JPMorgan Chase & Co.

(JPM) is the lower-risk stock at 0. 94β versus Canaan Inc. 's 4. 24β — meaning CAN is approximately 350% more volatile than JPM relative to the S&P 500. On balance sheet safety, Canaan Inc. (CAN) carries a lower debt/equity ratio of 13% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

04

Which is growing faster — ANL or CAN or MARA or ZLAB or JPM?

By revenue growth (latest reported year), Canaan Inc.

(CAN) is pulling ahead at 96. 7% versus -100. 0% for Adlai Nortye Ltd. (ANL). On earnings-per-share growth, the picture is similar: Adlai Nortye Ltd. grew EPS 68. 3% year-over-year, compared to -314. 5% for Marathon Digital Holdings, Inc.. Over a 3-year CAGR, ZLAB leads at 28. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ANL or CAN or MARA or ZLAB or JPM?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -833. 1% for Adlai Nortye Ltd. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -996. 4% for ANL. At the gross margin level — before operating expenses — ANL leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is ANL or CAN or MARA or ZLAB or JPM more undervalued right now?

Analyst consensus price targets imply the most upside for CAN: 337.

2% to $1. 40.

07

Which pays a better dividend — ANL or CAN or MARA or ZLAB or JPM?

In this comparison, JPM (1.

9% yield) pays a dividend. ANL, CAN, MARA, ZLAB do not pay a meaningful dividend and should not be held primarily for income.

08

Is ANL or CAN or MARA or ZLAB or JPM better for a retirement portfolio?

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Canaan Inc. (CAN) carries a higher beta of 4. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, CAN: -92. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between ANL and CAN and MARA and ZLAB and JPM?

These companies operate in different sectors (ANL (Healthcare) and CAN (Technology) and MARA (Financial Services) and ZLAB (Healthcare) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ANL is a small-cap quality compounder stock; CAN is a small-cap high-growth stock; MARA is a small-cap high-growth stock; ZLAB is a small-cap high-growth stock; JPM is a large-cap deep-value stock. JPM pays a dividend while ANL, CAN, MARA, ZLAB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.